Neuropsychiatric Systemic Lupus Erythematosus Manifestations Affecting the Quality of Life in Patients
DOI:
https://doi.org/10.12970/2310-9874.2014.02.03.5Keywords:
Systemic lupus erythematosus, neuropsychiatric manifestations, quality of life.Abstract
Systemic lupus erythematosus (SLE) is a systemic autoimmune disease that can affect any organ. With SLE, one should always take into account the possibility of nervous system involvement. The aim of this study was to answer the question about the quality of life in patients with SLE with or without neuropsychiatric manifestations. We created a simple questionnaire, consisting of seven simple questions concerning physical and mental quality of life. In addition, socioeconomic status of patients was evaluated. The study group consisted of 59 patients with a mean age 51.9±16.6 years. 9 of them had neuropsychiatric manifestations. The quality of life survey conducted in patients with SLE groups according to the presence of neuropsychiatric manifestations. In SLE patients with neuropsychiatric manifestations sleep disorder, was most common. This deteriorated their quality of life in the mental sphere.
References
Smolen JS. Therapy of systemic lupus erythematosus: a look into the future. Arthritis Res 2002; 4(Suppl 3): S25. http://dx.doi.org/10.1186/ar579
Ginzler EM, Moldovan I. Systemic lupus erythematosus trials: successes and issues. Curr Opin Rheumatol 2004; 16: 499. http://dx.doi.org/10.1097/01.bor.0000133659.14482.59
Goldblatt F, Isenberg DA. New therapies for systemic lupus erythematosus. Clin Expo Immunol 2005; 140: 205. http://dx.doi.org/10.1111/j.1365-2249.2005.02795.x
Wallace DJ. Improving the prognosis of SLE without prescribing lupus drugs and the primary care paradox. Lupus 2008; 17: 91. http://dx.doi.org/10.1177/0961203307086267
The American College of Rheumatology nomenclature and case definitions for neuropsychiatric lupus syndromes. Arthritis Rheum 1999; 42: 599-608. http://dx.doi.org/10.1002/1529-0131(199904)42:4<599::AID-ANR2>3.0.CO;2-F
Bertsias GK, Ioannidis JP, Aringer MI, et al. EULAR recommendations for the management of systemic lupus erythematosus with neuropsychiatric manifestations: report of a task force of the EULAR standing committee for clinical affairs. Ann Rheum Dis 2010; 69: 2074-82. http://dx.doi.org/10.1136/ard.2010.130476
Papescu A, Kao AH. Neuropsychiatric systemic lupus erythematosus. Curr Neuropharmac 2011; 9: 449-457. http://dx.doi.org/10.2174/157015911796557984
Hochberg MC. Updating The American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1997; 42: 1725. http://dx.doi.org/10.1002/art.1780400928
Scott DL, Garrood T. Quality of life measures: use and abuse. Baillieres Best Pract Res Clin Rheumatol 2000; 14: 663-87. http://dx.doi.org/10.1053/berh.2000.0106
Fries JF, Spitz P, Kraines RG, et al. Measurement of patients outcome in arthritis. Arthritis Rheum 1980; 23: 137-145. http://dx.doi.org/10.1002/art.1780230202
Meenan RF, Gertman PM, Mason JH. Measuring health status in arthritis. The arthritis impact measurement scales. Arthritis Rheum 1980; 23: 146-52. http://dx.doi.org/10.1002/art.1780230203
Ware JE Jr, Sherbourne CD. The MOS 36-item short-form health survey (SF-36).I. Conceptrual framework and item selection. Med Care 1992; 30: 473-83. http://dx.doi.org/10.1097/00005650-199206000-00002
Hanly JG, Urowitz MB, Su L, et al. Systemic Lupus International Collaborating Clinics (SLICC). Prospective analysis of neuropsychiatric events in an international disease inception cohort of patients with systemic lupus erythematosus. Ann Rheum Dis 2010; 69: 529-35. http://dx.doi.org/10.1136/ard.2008.106351
Sibbitt WL Jr, Brooks WM, Kornfeld M, et al. Magnetic resonance imaging and brain histopathology in neuropsychiatric systemic lupus erythematosus. Semin Arthritis Rheum 2010; 40: 32-52. http://dx.doi.org/10.1016/j.semarthrit.2009.08.005
Muscal E, Bloom DR, Hunter JV, et al. Frequency of neuro-psychiatric dysfunction in anti- SSA/SSB exposed children with and without neonatal lupus. Lupus 2010; 19: 300-6. http://dx.doi.org/10.1177/0961203309354542